Yadav Akshita, Bharat Brandon S, Montrose Stephanie
Family Medicine, Ross University School of Medicine, Bridgetown, BRB.
Family Medicine, Clarkston Medical Group, Clarkston, USA.
Cureus. 2022 Mar 23;14(3):e23432. doi: 10.7759/cureus.23432. eCollection 2022 Mar.
Selective serotonin reuptake inhibitors (SSRIs) are among the most widely used antidepressants worldwide. They are an effective first-line treatment for depression. Common side effects can be quickly remediated by switching to a different drug, making it easy to miss rare side effects and even causing them to go underreported. This case study examines an instance of uterine bleeding in a postmenopausal woman after starting an antidepressant. A detailed history determined that the medication was the only noticeable change in her daily routine before the onset of bleeding, making it the likely cause. Due to the high index of suspicion, the medication was discontinued, and it was apparent that the bleeding ceased. This phenomenon demonstrated the role of serotonin in potentiating the coagulation cascade. Research on this topic is limited, but there have been other reported cases of similar findings in the past.
选择性5-羟色胺再摄取抑制剂(SSRIs)是全球使用最广泛的抗抑郁药物之一。它们是治疗抑郁症的有效一线药物。常见的副作用可以通过换用其他药物迅速得到缓解,这使得罕见的副作用很容易被忽视,甚至导致报告不足。本病例研究考察了一名绝经后女性在开始服用抗抑郁药后出现子宫出血的情况。详细的病史显示,在出血开始前,该药物是她日常活动中唯一明显的变化,因此很可能是出血的原因。由于高度怀疑,停用了该药物,出血明显停止。这一现象证明了5-羟色胺在增强凝血级联反应中的作用。关于这一主题的研究有限,但过去也曾有其他类似发现的报告病例。